The Sleep Disorders Channel is supported through educational grants from Alkermes and Takeda.
VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.
Sleep Europe 2024 | A multi-center study on the effectiveness of the Daytime-Nighttime Appliance for OSA treatment
Clete Kushida, MD, PhD, Stanford University Medical Center, Redwood City, CA, discusses the Daytime-Nighttime Appliance (DNA), a slow maxillary expansion device for pediatric patients with obstructive sleep apnea (OSA). A multi-center study (NCT05661747) found that the DNA device demonstrated significant improvements in all measured outcomes. This device provides the option of a temporary oral appliance that can increase airway volume and improve OSA symptoms. This interview took place at the Sleep Europe 2024 congress in Seville, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
